Melinda Krakow1, Chelsea L Ratcliff2, Bradford W Hesse1, Alexandra J Greenberg-Worisek3. 1. Health Communication and Informatics Research Branch, National Cancer Institute, Bethesda, Maryland, USA. 2. Department of Communication, University of Utah, Salt Lake City, Utah, USA. 3. Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Abstract
BACKGROUND/AIMS: Public understanding of the role of genetics in disease risk is key to appropriate disease prevention and detection. This study assessed the current extent of awareness and use of genetic testing in the US population. Additionally, the study identified characteristics of subgroups more likely to be at risk for low genetic literacy. METHODS: The study used data from the National Cancer Institute's 2017 Health Information National Trends Survey, including measures of genetic testing awareness, genetic testing applications and genetic testing usage. Multivariable logistic regression models estimated associations between sociodemographics, genetic testing awareness, and genetic testing use. RESULTS: Fifty-seven percent of respondents were aware of genetic tests. Testing awareness differed by age, household income, and race/ethnicity. Most participants had heard of using tests to determine personal disease risk (82.58%) or inherited disease risk in children (81.41%), but less were familiar with determining treatment (38.29%) or drug efficacy (40.76%). Among those with genetic testing awareness, actual testing uptake was low. CONCLUSIONS: A large portion of the general public lacks genetic testing awareness and may benefit from educational campaigns. As precision medicine expands, increasing public awareness about genetic testing applications for disease prevention and treatment will be important to support population health. This is a work of the US Government and is not subject to copyright protection in the United States. Foreign copyrights may apply. Published by S. Karger AG, Basel.
BACKGROUND/AIMS: Public understanding of the role of genetics in disease risk is key to appropriate disease prevention and detection. This study assessed the current extent of awareness and use of genetic testing in the US population. Additionally, the study identified characteristics of subgroups more likely to be at risk for low genetic literacy. METHODS: The study used data from the National Cancer Institute's 2017 Health Information National Trends Survey, including measures of genetic testing awareness, genetic testing applications and genetic testing usage. Multivariable logistic regression models estimated associations between sociodemographics, genetic testing awareness, and genetic testing use. RESULTS: Fifty-seven percent of respondents were aware of genetic tests. Testing awareness differed by age, household income, and race/ethnicity. Most participants had heard of using tests to determine personal disease risk (82.58%) or inherited disease risk in children (81.41%), but less were familiar with determining treatment (38.29%) or drug efficacy (40.76%). Among those with genetic testing awareness, actual testing uptake was low. CONCLUSIONS: A large portion of the general public lacks genetic testing awareness and may benefit from educational campaigns. As precision medicine expands, increasing public awareness about genetic testing applications for disease prevention and treatment will be important to support population health. This is a work of the US Government and is not subject to copyright protection in the United States. Foreign copyrights may apply. Published by S. Karger AG, Basel.
Entities:
Keywords:
Awareness; Genetic education; Genetic literacy; Genetic testing; Health communication; Health information; Knowledge; Knowledge gap; Population survey
Authors: Katrina A B Goddard; Debra Duquette; Amy Zlot; Jenny Johnson; Ann Annis-Emeott; Patrick W Lee; Mary Pat Bland; Karen L Edwards; Kristin Oehlke; Rebecca T Giles; Ann Rafferty; Michelle L Cook; Muin J Khoury Journal: Am J Public Health Date: 2008-12-23 Impact factor: 9.308
Authors: Colleen M McBride; Deborah Bowen; Lawrence C Brody; Celeste M Condit; Robert T Croyle; Marta Gwinn; Muin J Khoury; Laura M Koehly; Bruce R Korf; Theresa M Marteau; Kenneth McLeroy; Kevin Patrick; Thomas W Valente Journal: Am J Prev Med Date: 2010-05 Impact factor: 5.043
Authors: Muin J Khoury; Michael S Bowen; Wylie Burke; Ralph J Coates; Nicole F Dowling; James P Evans; Michele Reyes; Jeannette St Pierre Journal: Am J Prev Med Date: 2011-04 Impact factor: 5.043
Authors: Katie L Lewis; Paul K J Han; Gillian W Hooker; William M P Klein; Leslie G Biesecker; Barbara B Biesecker Journal: PLoS One Date: 2015-07-17 Impact factor: 3.240
Authors: Belen Hurle; Toby Citrin; Jean F Jenkins; Kimberly A Kaphingst; Neil Lamb; Jo Ellen Roseman; Vence L Bonham Journal: Genet Med Date: 2013-02-28 Impact factor: 8.822
Authors: Sheila V Kusnoor; Taneya Y Koonce; Mia A Levy; Christine M Lovly; Helen M Naylor; Ingrid A Anderson; Christine M Micheel; Sheau-Chiann Chen; Fei Ye; Nunzia B Giuse Journal: AMIA Jt Summits Transl Sci Proc Date: 2016-07-20
Authors: Kenneth P Tercyak; Suzanne M Bronheim; Nicole Kahn; Hillary A Robertson; Bruno J Anthony; Darren Mays; Suzanne C O'Neill; Susan K Peterson; Susan Miesfeldt; Beth N Peshkin; Tiffani A DeMarco Journal: Transl Behav Med Date: 2019-05-16 Impact factor: 3.046
Authors: Ilana B Solomon; Sarah McGraw; Jenny Shen; Adem Albayrak; Gil Alterovitz; Melanie Davies; Catherine Del Vecchio Fitz; Rachel A Freedman; Lisa N Lopez; Lynette M Sholl; Eliezer Van Allen; Joanne Mortimer; Marwan Fakih; Sumanta Pal; Karen L Reckamp; Yuan Yuan; Stacy W Gray Journal: JCO Precis Oncol Date: 2020-04-14
Authors: Teala W Alvord; Lisa K Marriott; Phuc T Nguyen; Autumn Shafer; Kim Brown; Wesley Stoller; Jennifer L Volpi; Jill Vandehey-Guerrero; Laura K Ferrara; Steven Blakesley; Erin Solomon; Hannah Kuehl; Amy J Palma; Paige E Farris; Kelly J Hamman; Madisen Cotter; Jackilen Shannon Journal: J Genet Couns Date: 2020-03-27 Impact factor: 2.537
Authors: Eric D Green; Chris Gunter; Leslie G Biesecker; Valentina Di Francesco; Carla L Easter; Elise A Feingold; Adam L Felsenfeld; David J Kaufman; Elaine A Ostrander; William J Pavan; Adam M Phillippy; Anastasia L Wise; Jyoti Gupta Dayal; Britny J Kish; Allison Mandich; Christopher R Wellington; Kris A Wetterstrand; Sarah A Bates; Darryl Leja; Susan Vasquez; William A Gahl; Bettie J Graham; Daniel L Kastner; Paul Liu; Laura Lyman Rodriguez; Benjamin D Solomon; Vence L Bonham; Lawrence C Brody; Carolyn M Hutter; Teri A Manolio Journal: Nature Date: 2020-10-28 Impact factor: 49.962
Authors: Sukh Makhnoon; Robert Yu; Sonia A Cunningham; Susan K Peterson; Sanjay Shete Journal: Public Health Genomics Date: 2021-04-22 Impact factor: 2.000
Authors: Ky'Era V Actkins; Swetha Srinivasan; Lisa P Spees; Erin Turbitt; Caitlin G Allen; Megan C Roberts Journal: Cancer Prev Res (Phila) Date: 2021-08-02
Authors: Shannon M Blee; Rachel Pocock Shah; Ana P M Pinheiro; Jeffrey Switchenko; Margie Dixon; Taofeek K Owonikoko; Charles E Hill; Stephen M Szabo; Rebecca D Pentz Journal: Oncologist Date: 2021-08-24